This brand name is authorized in Austria, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, United Kingdom, South Africa
The drug EVRA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Norelgestromin
UNII R0TAY3X631 - NORELGESTROMIN
|
|
|
|
2
17 alpha-Ethinylestradiol
UNII 423D2T571U - ETHINYL ESTRADIOL
|
|
Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| EVRA Plaster | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03AA13 | Norelgestromin and ethinylestradiol | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 514500701174311 |
| Country: CA | Health Products and Food Branch | Identifier(s): 02248297 |
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 26.190-02-05 |
| Country: EE | Ravimiamet | Identifier(s): 1131589, 1131590, 1131602 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 02223001, 02223001IP, 02223001IP1, 02223001IP2, 02223001IP3, 02223001IP4, 02223002, 02223002IP1, 02223002IP2, 02223002IP3 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 012921, 013101, 013107 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69729088 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 46088 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 24402, 24408 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4723, 4724 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 035684012, 035684024, 035684036, 045753011, 048236018, 049088014 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1012652, 1012653, 1012654 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 381M2002 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14810735 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 121711 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100113907 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W68023001, W68023002, W68023003 |
| Country: SG | Health Sciences Authority | Identifier(s): 12423P |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 36/18.7/0491 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
